Results 251 to 260 of about 28,985 (310)
Some of the next articles are maybe not open access.
Immunosuppressive Agents in Dermatology
Dermatologic Clinics, 1993Azathioprine, cyclophosphamide, and cyclosporine are immunosuppressive agents commonly used by dermatologists. Azathioprine has a good safety profile and is preferred by most dermatologists for the treatment of bullous pemphigoid, cutaneous vasculitides, chronic eczematous dermatitides, and cutaneous manifestations of connective tissue diseases.
V C, Ho, D M, Zloty
openaire +2 more sources
Dermatologic Toxicity of Chemotherapeutic Agents
Seminars in Oncology, 2006Due to its high metabolic rate, skin represents one of the major target organs of chemotherapy-associated toxicity. Reactions range from common, nonspecific exanthematous eruptions to rare but distinctive cutaneous lesions that may not become apparent until a drug transitions from clinical trials to widespread oncologic use.
Aimee S, Payne +2 more
openaire +2 more sources
Topical Antibacterial Agents in Dermatology
The Journal of Dermatology, 2003AbstractTopical antibacterials are being widely used for the treatment or prevention of superficial bacterial infections. Emergence of drug resistant mutant strains of microorganisms and development of irritant and allergic contact dermatitis is a common problem with many of the topical antibacterials.
Anjum, Singal, Gurvinder P, Thami
openaire +2 more sources
Dermatologic Therapy With Immunosuppressive Agents
Postgraduate Medicine, 1975The use of powerful immunosuppressive agents such as methotrexate, cyclophosphamide, and azathioprine in the treatment of serious skin diseases is a relatively recent development whose efficacy is borne out in many studies. Using an immunosuppressant often makes possible an appreciable reduction in dosage of steroid necessary to control disease and, in
R I, Rudolph, J J, Leyden
openaire +2 more sources
Allergy to Dermatologic Agents
JAMA: The Journal of the American Medical Association, 1966Between 1962 and 1965, 78 cases of allergy to topically administered medicaments were documented in the author's private practice. In 60 of the 78 patients the allergy had been responsible for causing or aggravating a dermatitis. Antimicrobials, antihistamines, and anesthetics were the most prominent allergens with neomycin being the single most ...
openaire +2 more sources
Cytokine blocking agents in dermatology.
Clinical and experimental dermatology, 2002Cytokines are intercellular messengers that have an important role in the development and maintenance of cutaneous inflammation. The primacy of cytokines in eliciting cutaneous immune responses makes them a highly attractive target for new biological response modifiers. Targeting of cytokines is still in its infancy for therapy of skin disease. However,
Williams, Jason D L, Griffiths, C. E M
openaire +3 more sources
Psychotropic Agents in Dermatology
Dermatologic Clinics, 1993In this article, relatively detailed explanation of the use of selected psychopharmacologic agents is given along with their dermatologic and psychodermatologic indications. For a more complete description of the use of these medications, the reader is advised to consult standard textbooks on psychopharmacology and the Physician's Desk Reference.
openaire +2 more sources
[Biological dermatologic agents. The Danish Society of Dermatology].
Ugeskrift for laeger, 2007Udgivelsesdato: Mar ...
Iversen, Lars, Kragballe, Knud
openaire +2 more sources
Dermatological pharmacology: topical agents
Medicine, 2004Topical therapies constitute an important aspect of dermatological treatments. This article covers the principles of topical treatments, the vehicles used and a number of commonly used topical agents, including corticosteroids. Indications for use and common adverse effects of these topical agents are outlined.
openaire +1 more source
New antiviral agents for dermatologic disease
Seminars in Cutaneous Medicine and Surgery, 1998The topic of antiviral agents for dermatologic disease is an area that is rapidly changing and expanding as our knowledge of herpes viruses, HIV, and human papilloma viruses continues to expand. New drugs are continuing to make therapy for these viruses more efficacious day by day.
S, Carlton, T, Evans, S K, Tyring
openaire +2 more sources

